Kristen Harrington-Smith

Insider Reports History

Location
Waltham, MA
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Kristen Harrington-Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen Harrington-Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. SVP & CHIEF COMMERCIAL OFFICER Restricted Stock Unit 50,000 $1,470,000 $29.40 15 Nov 2022 Direct
ImmunoGen, Inc. SVP & CHIEF COMMERCIAL OFFICER Common Stock 25,000 $741,000 $29.64 15 Nov 2022 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 800 13 Jun 2024 Direct

Insider Reports Filed by Kristen Harrington-Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024073202-harrington-smith-kristen-2024-06-13 eFFECTOR Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 13 Jun 2024, 18:23
/report/000120919124003693-harrington-smith-kristen-2024-02-19 eFFECTOR Therapeutics, Inc. 19 Feb 2024 1 $0 4 Director 21 Feb 2024, 17:20
/report/000120919123039197-harrington-smith-kristen-2023-06-22 eFFECTOR Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 22 Jun 2023, 20:12
/report/000120919123004587-harrington-smith-kristen-2023-01-20 eFFECTOR Therapeutics, Inc. 20 Jan 2023 1 $0 4 Director 24 Jan 2023, 15:13
/report/000141588922011604-harrington-smith-kristen-2022-11-15 ImmunoGen, Inc. 15 Nov 2022 2 $0 4 SVP & CHIEF COMMERCIAL OFFICER 18 Nov 2022, 16:31
/report/000120919122036448-harrington-smith-kristen-2022-06-09 eFFECTOR Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:46
/report/000120919122010985-harrington-smith-kristen-2022-02-15 eFFECTOR Therapeutics, Inc. 15 Feb 2022 1 $0 4 Director 17 Feb 2022, 17:26
/report/000120919122010983-harrington-smith-kristen-2022-02-15 eFFECTOR Therapeutics, Inc. 15 Feb 2022 0 $0 3 Director 17 Feb 2022, 17:24
/report/000117911021010217-harrington-smith-kristen-2021-11-15 ImmunoGen, Inc. 15 Nov 2021 2 +$2,556,000 4 SVP & Chief Commercial Officer 17 Nov 2021, 15:14
/report/000117911021010215-harrington-smith-kristen-2021-11-15 ImmunoGen, Inc. 15 Nov 2021 0 $0 3 SVP & Chief Commercial Officer 17 Nov 2021, 15:12